Review:
Medullary Thyroid Cancer
overall review score: 3.8
⭐⭐⭐⭐
score is between 0 and 5
Medullary thyroid cancer (MTC) is a type of neuroendocrine tumor that originates from the parafollicular C cells of the thyroid gland. Unlike the more common papillary and follicular thyroid cancers, MTC accounts for approximately 3-4% of all thyroid cancers. It can occur sporadically or as part of genetic syndromes such as Multiple Endocrine Neoplasia (MEN) types 2A and 2B. MTC often manifests as a painless neck mass and may produce calcitonin, which serves as a tumor marker. Early detection and treatment are crucial for improving prognosis.
Key Features
- Derived from parafollicular (C) cells of the thyroid
- May be sporadic or hereditary (linked to MEN syndromes)
- Produces calcitonin, which can be used for diagnosis and monitoring
- Often presents as a painless neck lump
- Potential for early metastasis to lymph nodes and distant sites
- Treatment primarily involves surgical removal of the tumor
Pros
- Potentially curable if detected early
- Specific tumor marker (calcitonin) aids in diagnosis and follow-up
- Hereditary forms allow for genetic screening and early intervention
Cons
- Can be aggressive with significant risk of metastasis
- Diagnosis may sometimes be delayed due to non-specific symptoms
- Treatment options are limited if diagnosed at an advanced stage
- Rare occurrence but associated with hereditary syndromes requiring further management